Xavier Bertin

Xavier Bertin is an experienced executive in the pharmaceutical industry, currently serving as Senior Vice-President of the Thrombosis Global Business Unit at LEO Pharma since April 2010, with full worldwide responsibility for thrombosis. Previously, Xavier held various roles at LEO Pharma, including President and CEO of LEO Pharma Canada and Business Unit Director for the Thrombosis Business Unit. Prior to LEO Pharma, Xavier worked at Merck Serono and Serono, where significant achievements included managing the Neurology franchise in France and enhancing sales contributions for biotech products. Xavier holds a CAAE from Nantes Université and a maîtrise in biology from the same institution.